vs
RHYTHM PHARMACEUTICALS, INC.（RYTM）与Stran & Company, Inc.（SWAG）财务数据对比。点击上方公司名可切换其他公司
RHYTHM PHARMACEUTICALS, INC.的季度营收约是Stran & Company, Inc.的2.1倍（$60.1M vs $28.9M），Stran & Company, Inc.净利率更高（0.8% vs -92.6%，领先93.4%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（83.8% vs 7.2%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（43.8% vs 24.0%）
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
Stran & Company, Inc.是品牌促销产品、定制周边及一体化营销解决方案供应商，服务覆盖零售、医疗、科技、教育等领域企业客户，助力客户开展品牌宣传、用户运营及员工激励相关工作。
RYTM vs SWAG — 直观对比
营收规模更大
RYTM
是对方的2.1倍
$28.9M
营收增速更快
RYTM
高出76.6%
7.2%
净利率更高
SWAG
高出93.4%
-92.6%
两年增速更快
RYTM
近两年复合增速
24.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $60.1M | $28.9M |
| 净利润 | $-55.6M | $243.0K |
| 毛利率 | 88.1% | 30.4% |
| 营业利润率 | -87.1% | -0.1% |
| 净利率 | -92.6% | 0.8% |
| 营收同比 | 83.8% | 7.2% |
| 净利润同比 | — | 141.5% |
| 每股收益（稀释后） | $-0.83 | $0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RYTMSWAG
| Q1 26 | $60.1M | — | ||
| Q4 25 | $57.3M | $28.9M | ||
| Q3 25 | $51.3M | $26.0M | ||
| Q2 25 | $48.5M | $32.6M | ||
| Q1 25 | $32.7M | $28.7M | ||
| Q4 24 | $41.8M | $27.0M | ||
| Q3 24 | $33.3M | $20.1M | ||
| Q2 24 | $29.1M | $16.7M |
净利润RYTMSWAG
| Q1 26 | $-55.6M | — | ||
| Q4 25 | $-47.5M | $243.0K | ||
| Q3 25 | $-52.9M | $-1.2M | ||
| Q2 25 | $-46.6M | $643.0K | ||
| Q1 25 | $-49.5M | $-393.0K | ||
| Q4 24 | $-43.3M | $-586.0K | ||
| Q3 24 | $-43.6M | $-2.0M | ||
| Q2 24 | $-32.3M | $-1.0M |
毛利率RYTMSWAG
| Q1 26 | 88.1% | — | ||
| Q4 25 | 91.6% | 30.4% | ||
| Q3 25 | 89.3% | 27.2% | ||
| Q2 25 | 88.6% | 30.3% | ||
| Q1 25 | 88.8% | 29.6% | ||
| Q4 24 | 90.9% | 32.5% | ||
| Q3 24 | 88.5% | 29.5% | ||
| Q2 24 | 89.9% | 32.8% |
营业利润率RYTMSWAG
| Q1 26 | -87.1% | — | ||
| Q4 25 | -82.2% | -0.1% | ||
| Q3 25 | -102.6% | -6.9% | ||
| Q2 25 | -93.4% | 1.2% | ||
| Q1 25 | -143.7% | -1.9% | ||
| Q4 24 | -98.6% | -3.5% | ||
| Q3 24 | -132.0% | -10.8% | ||
| Q2 24 | -139.2% | -6.6% |
净利率RYTMSWAG
| Q1 26 | -92.6% | — | ||
| Q4 25 | -83.0% | 0.8% | ||
| Q3 25 | -103.1% | -4.8% | ||
| Q2 25 | -96.1% | 2.0% | ||
| Q1 25 | -151.4% | -1.4% | ||
| Q4 24 | -103.6% | -2.2% | ||
| Q3 24 | -131.2% | -10.1% | ||
| Q2 24 | -110.9% | -6.1% |
每股收益（稀释后）RYTMSWAG
| Q1 26 | $-0.83 | — | ||
| Q4 25 | $-0.73 | $0.02 | ||
| Q3 25 | $-0.82 | $-0.07 | ||
| Q2 25 | $-0.75 | $0.03 | ||
| Q1 25 | $-0.81 | $-0.02 | ||
| Q4 24 | $-0.71 | $-0.02 | ||
| Q3 24 | $-0.73 | $-0.11 | ||
| Q2 24 | $-0.55 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $340.6M | $11.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $122.9M | $30.5M |
| 总资产 | $442.3M | $49.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资RYTMSWAG
| Q1 26 | $340.6M | — | ||
| Q4 25 | $388.9M | $11.6M | ||
| Q3 25 | $416.1M | $11.8M | ||
| Q2 25 | $291.0M | $18.1M | ||
| Q1 25 | $314.5M | $12.2M | ||
| Q4 24 | $320.6M | $18.2M | ||
| Q3 24 | $298.4M | $6.9M | ||
| Q2 24 | $319.1M | $9.6M |
股东权益RYTMSWAG
| Q1 26 | $122.9M | — | ||
| Q4 25 | $139.1M | $30.5M | ||
| Q3 25 | $148.8M | $30.2M | ||
| Q2 25 | $-11.9M | $31.8M | ||
| Q1 25 | $18.9M | $31.3M | ||
| Q4 24 | $21.7M | $31.6M | ||
| Q3 24 | $11.2M | $32.3M | ||
| Q2 24 | $39.3M | $34.3M |
总资产RYTMSWAG
| Q1 26 | $442.3M | — | ||
| Q4 25 | $480.2M | $49.3M | ||
| Q3 25 | $506.9M | $50.3M | ||
| Q2 25 | $372.7M | $61.2M | ||
| Q1 25 | $386.7M | $52.2M | ||
| Q4 24 | $392.3M | $55.1M | ||
| Q3 24 | $363.6M | $48.8M | ||
| Q2 24 | $381.8M | $46.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $161.0K |
| 自由现金流经营现金流 - 资本支出 | — | $38.0K |
| 自由现金流率自由现金流/营收 | — | 0.1% |
| 资本支出强度资本支出/营收 | — | 0.4% |
| 现金转化率经营现金流/净利润 | — | 0.66× |
| 过去12个月自由现金流最近4个季度 | — | $-5.5M |
8季度趋势，按日历期对齐
经营现金流RYTMSWAG
| Q1 26 | — | — | ||
| Q4 25 | $-25.4M | $161.0K | ||
| Q3 25 | $-26.6M | $-5.4M | ||
| Q2 25 | $-23.3M | $6.4M | ||
| Q1 25 | $-40.4M | $-5.9M | ||
| Q4 24 | $-18.8M | $1.3M | ||
| Q3 24 | $-25.2M | $-2.7M | ||
| Q2 24 | $-29.1M | $2.1M |
自由现金流RYTMSWAG
| Q1 26 | — | — | ||
| Q4 25 | — | $38.0K | ||
| Q3 25 | — | $-5.9M | ||
| Q2 25 | — | $6.3M | ||
| Q1 25 | — | $-6.0M | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | $-2.9M | ||
| Q2 24 | — | $1.9M |
自由现金流率RYTMSWAG
| Q1 26 | — | — | ||
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | -22.6% | ||
| Q2 25 | — | 19.5% | ||
| Q1 25 | — | -21.0% | ||
| Q4 24 | — | 4.6% | ||
| Q3 24 | — | -14.3% | ||
| Q2 24 | — | 11.6% |
资本支出强度RYTMSWAG
| Q1 26 | — | — | ||
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% |
现金转化率RYTMSWAG
| Q1 26 | — | — | ||
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 9.99× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RYTM
暂无分部数据
SWAG
| Promotional Products Dropshipping | $11.2M | 39% |
| Casino Continuity Program | $6.9M | 24% |
| Promotional Products Company Owned Inventory | $4.6M | 16% |
| Promotional Products Bulk Dropshipping | $3.8M | 13% |
| Promotional Products Thirdparty Distributor | $1.8M | 6% |
| Other | $610.0K | 2% |
